Common Shares Outstanding: The number of class A shares currently held by investors.
NovoCure Limited (NVCR) had Common Shares Outstanding of 111.48M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$154.99M |
|
$-34.32M |
|
$38.52M |
|
$116.47M |
|
$192.86M |
|
$-37.87M |
|
$7.57M |
|
$-30.30M |
|
$-30.30M |
|
$-34.32M |
|
$-34.32M |
|
$-34.32M |
|
$-34.32M |
|
$-37.87M |
|
$-41.19M |
|
110.28M |
|
110.28M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$1.09B |
|
$96.51M |
|
$159.51M |
|
$1.25B |
|
$743.30M |
|
$97.45M |
|
$143.55M |
|
$886.85M |
|
$361.96M |
|
$361.96M |
|
$361.96M |
|
|
Common Shares Outstanding |
111.48M |
| Cash Flow Statement Financials | |
$-35.66M |
|
$-6.47M |
|
$5.25M |
|
$166.09M |
|
$129.43M |
|
$-36.66M |
|
$29.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.47 |
|
-- |
|
-- |
|
0.21 |
|
1.81 |
|
75.15% |
|
-24.43% |
|
-24.43% |
|
-- |
|
-19.55% |
|
-22.14% |
|
$-46.28M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.98 |
|
1.31 |
|
68.84 |
|
-9.48% |
|
-9.48% |
|
-2.75% |
|
-7.47% |
|
$3.25 |
|
$-0.42 |
|
$-0.32 |
|